![](https://endpts.com/wp-content/uploads/2020/10/Robert-Duggan-Summit-wikimedia-tile-scaled.jpg)
Bob Duggan, Summit Therapeutics CEO (Kelly Morfopoulos via Wikimedia)
Updated: With a promising new Keytruda contender, Summit prepares to spar with Merck
CHICAGO — Summit Therapeutics is prepared to take on the world’s best-selling drug.
On Thursday, the biotech’s stock nearly tripled after reporting that its cancer drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.